Stock AnalizCalumet, Inc. CLMT
Integrated oil Companies · IPO 2006 · data as of November 13, 2026
Calumet, Inc. (CLMT) is a energy company listed in the US with a market value of about $3.0B. In the twelve months to September 30, 2026 it had revenue of $5.2B and net income of -$194M, a net margin of -3.7%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is value (1/5); the weakest is track record (0/5).
Key numbers: a price to free cash flow of 11.4, a 5-year average ROIC of 8%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 50% below the current price.
Score: 0.8 / 5
Checks passed
- P/FCF below 20
- Profit margin improving
- Positive free cash flow
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 4 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $5.2B | $4.1B | $4.2B | $4.2B | $4.7B |
| Net income | -$194M | -$34M | -$222M | $48M | -$173M |
| Free cash flow | $265M | $57M | -$123M | -$287M | -$436M |
| EPS (diluted) | $-2.25 | $-0.39 | $-2.67 | $0.60 | $-2.18 |
| Net margin | -3.7% | -0.8% | -5.3% | 1.1% | -3.7% |
| ROIC | — | 5.0% | 0.4% | 17.1% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 5 analysts is $55.80, 63% above the current price; targets range from $40.00 to $75.00; the consensus rating is “Buy”; expected EPS is $0.68 for the fiscal year ending December 31, 2026.
Frequently asked questions
Is Calumet stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 50% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Calumet pay a dividend?
Not currently.
Is Calumet a good stock to buy?
We do not give buy or sell advice. Calumet scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.